[Inhibition of mammary carcinogenesis of C3H/f mice with broparestrol].
Administration of bromotriphenylethylene to C3H/f female mice implanted with a pituitary under the kidney capsule produce an inhibition of mammary carcinogenesis with high doses (20 ppm or 200 ppm in the diet). With a diet containing 2 ppm no inhibition is observed.
D000818:Animals; D004305:Dose-Response Relationship, Drug; D045166:Estradiol Congeners / Q000627:therapeutic use*; D005260:Female; D008325:Mammary Neoplasms, Experimental / Q000517:prevention & control*; D051379:Mice; D008815:Mice, Inbred Strains; D010902:Pituitary Gland; D013267:Stilbenes / Q000627:therapeutic use*
D045166:Estradiol Congeners; D013267:Stilbenes
Inhibition de la cancérogenèse mammaire des souris C3H/f à l'aide du broparestrol.